Novasenta

Novasenta

Biotechnology, 350 Technology Dr Ste 501, Pittsburgh, Pennsylvania, 15219, United States, 11-50 Employees

novasenta.com

  • twitter
  • LinkedIn

phone no Phone Number: 14*********

Who is NOVASENTA

Novasenta discovers novel therapeutic targets to develop innovative and effective treatments with the goal of transforming the lives of patients with cancer. We use systematic, rigorous, ...

Read More

map
  • 350 Technology Dr Ste 501, Pittsburgh, Pennsylvania, 15219, United States Headquarters: 350 Technology Dr Ste 501, Pittsburgh, Pennsylvania, 15219, United States
  • 2019 Date Founded: 2019
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Deborah Kroll CEO:   Deborah Kroll

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from NOVASENTA

Novasenta Org Chart and Mapping

Deborah Kroll

Executive Assistant to Chief Executive Officer

Employees

Deborah Kroll

Executive Assistant to the Ceo/Office Manager

Sreeram Balasubramanian

Associate Director, Computational Sciences

Karsen Shoger

Senior Research Associate

Jiayi Yu

Executive Director, Head of R&D Operations

Zachary Lash

Senior Software Engineer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Novasenta

Answer: Novasenta's headquarters are located at 350 Technology Dr Ste 501, Pittsburgh, Pennsylvania, 15219, United States

Answer: Novasenta's phone number is 14*********

Answer: Novasenta's official website is https://novasenta.com

Answer: Novasenta's revenue is $1 Million to $5 Million

Answer: Novasenta's SIC: 8731

Answer: Novasenta's NAICS: 541714

Answer: Novasenta has 11-50 employees

Answer: Novasenta is in Biotechnology

Answer: Novasenta contact info: Phone number: 14********* Website: https://novasenta.com

Answer: Novasenta discovers novel therapeutic targets to develop innovative and effective treatments with the goal of transforming the lives of patients with cancer. We use systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, immune response, and metabolism. Single-cell level analysis of high-quality, human tumor samples combined with the advanced data mining abilities of our research and computational biology teams accelerate the path from discovery to patient. Our goal is to identify novel targets to generate effective therapies for a range of cancers.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access